
Loading, please wait...

Loading, please wait...

A recent study published in JMIR AI suggests that machine learning can accurately determine a patient's biological sex and estimate their physiological lung age from pulmonary function tests (PFTs). This lung age prediction approach provides a more intuitive understanding of respiratory health compared to traditional metrics. Consequently, clinicians may soon use these artificial intelligence models to enhance patient communication and monitoring.
Researchers from the Mayo Clinic analyzed retrospective data from 6,392 healthy adults across three regions. They developed gradient-boosted machine models to analyze various PFT parameters, including time-series features. The goal was to determine if artificial intelligence could go beyond standard interpretation to reveal underlying biological patterns related to aging and sex.
The most advanced model achieved a mean absolute error of only 5.55 years in predicting chronological age. Moreover, the sex classification model demonstrated exceptional performance with an area under the curve (AUC) of 0.981. Key predictors for these models included peak expiratory flow, height, and residual volume as a percentage of total lung capacity. Therefore, these findings suggest that AI can extract highly specific physiological markers from routine lung tests.
Although the models tended to overestimate age in younger individuals and underestimate it in older adults, they consistently followed chronological trends. This suggests that physiological lung age could become a valuable biomarker for monitoring lung aging and overall wellness. Furthermore, the ability to predict biological sex with 91.7% sensitivity highlights the profound anatomical differences captured by PFT data.
In conclusion, the integration of AI into pulmonary diagnostics offers a promising pathway for personalized medicine. However, further validation in diverse patient populations is necessary before widespread clinical adoption. Ultimately, this technology could revolutionize how we interpret lung function and manage chronic respiratory conditions.
AI models analyze complex patterns within PFT data, such as airflow volume and capacity. They compare these metrics against large datasets to determine how closely a person's lung function matches specific age groups, resulting in a lung age prediction.
Lung age offers an easy-to-understand metric for patients. This can potentially increase motivation for smoking cessation or adherence to respiratory treatments by making the impact of lung health more tangible.
Currently, these AI models are designed to supplement traditional interpretation. They provide additional context regarding physiological aging rather than replacing standard clinical diagnosis.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Johnson PW et al. Estimating a Physiological Lung Function Score and Biological Sex Using Pulmonary Function Tests and Machine Learning: Retrospective Study. JMIR AI. 2026 Jun 01. doi: 10.2196/89060. PMID: 42224015.
Topalovic M, et al. Artificial intelligence for interpreting pulmonary function tests. Eur Respir J. 2019;53(3):1801703. doi: 10.1183/13993003.01703-2018.
American Thoracic Society. Standardizing PFT Interpretation. 2022.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Mayo Clinic researchers developed AI models to predict lung age and sex from PFT data, achieving high accuracy and offering a new way to assess lung health....
last month

The Delhi High Court has issued a notice to the Centre and FSSAI regarding a plea for an India-specific scientific evaluation of non-sugar sweeteners. The petition highlights concerns over metabolic risks, front-of-pack labeling, and misleading health claims on artificial substitutes.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
4 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
5 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
4 days back

A UK Biobank study of 471,540 participants reveals that metabolic syndrome increases incident gastric cancer risk by 36% (HR=1.36). A positive trend was observed with accumulating metabolic components, with waist circumference showing the strongest association, highlighting modifiable risk targets.
5 days back